Research and analysis

Herpes zoster (shingles) immunisation programme 2013 to 2014: evaluation report

Evaluation of the first year of the shingles vaccination programme in England and a summary of PHE's ongoing surveillance activities.

Documents

Herpes zoster (shingles) immunisation programme 2013 to 2014: report for England

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingles vaccine coverage in England by age cohort and Clinical Commissioning Group: 1 September 2013 to 31 August 2014

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The shingles vaccination programme aims to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals’ pre-existing varicella zoster virus immunity.

This report highlights the successful implementation of the shingles vaccine programme in England.

In the first year of the programme (2013 to 2014), the vaccine was routinely offered to adults:

  • aged 70 years on 1 September 2013 (born between 2 September 1942 and 1 September 1943)
  • aged 79 on 1 September 2013 (born between 2 September 1933 and 1 September 1934)
Published 4 December 2014
Last updated 19 December 2014 + show all updates
  1. Added shingles vaccine coverage figures by age and CCG.
  2. First published.